Stada plots path forward with Goldschmidt at helm
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
“Continuing to market a competitive portfolio” and “working closely with our global network of strategic development and production partners” are among the long-term priorities of Stada Arzneimittel’s newly-appointed chief executive officer Peter Goldschmidt.